Gain Therapeutics, Inc. is a biotech company developing small molecule therapeutics for various diseases through its Magellan drug discovery platform. Their lead candidate, GT-02287, targets GBA1 Parkinson's disease.
Read MoreDid you find this insightful?
Bad
Just Okay
Amazing